Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Nuclear Medicine and Biology
|
January 1, 1996
Radiotracer binding to brain microsomes determined by thin-layer chromatography
P O Zamora, M Stratesteffan, S Guhlke, et al.
Anticancer Research
|
May 1, 1997
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment
F F Knapp, A L Beets, S Guhlke, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
July 19, 2005
A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use
J Schmaljohann, D Gündisch, M Minnerop, et al.
Nuclear Medicine and Biology
|
November 6, 1998
188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling
S Guhlke, A Schaffland, P O Zamora, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1996
Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs
M Hosono, M N Hosono, T Haberberger, et al.
Annals of Nuclear Medicine
|
June 24, 1998
Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice
M N Hosono, M Hosono, P O Zamora, et al.
European Journal of Nuclear Medicine
|
February 7, 2001
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
H Palmedo, S Guhlke, H Bender, et al.
Nuklearmedizin. Nuclear Medicine
|
August 22, 2013
Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate
S Ezziddin, K Reichmann, C Yong-Hing, et al.
Nuklearmedizin. Nuclear Medicine
|
April 30, 2014
Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement
A Sabet, F Khalaf, C J Yong-Hing, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Nuclear Medicine and Biology
|
January 1, 1996
Radiotracer binding to brain microsomes determined by thin-layer chromatography
P O Zamora, M Stratesteffan, S Guhlke, et al.
Anticancer Research
|
May 1, 1997
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment
F F Knapp, A L Beets, S Guhlke, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
July 19, 2005
A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use
J Schmaljohann, D Gündisch, M Minnerop, et al.
Nuclear Medicine and Biology
|
November 6, 1998
188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling
S Guhlke, A Schaffland, P O Zamora, et al.
Japanese Journal of Cancer Research : Gann
|
September 1, 1996
Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs
M Hosono, M N Hosono, T Haberberger, et al.
Annals of Nuclear Medicine
|
June 24, 1998
Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice
M N Hosono, M Hosono, P O Zamora, et al.
European Journal of Nuclear Medicine
|
February 7, 2001
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
H Palmedo, S Guhlke, H Bender, et al.
Nuklearmedizin. Nuclear Medicine
|
August 22, 2013
Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate
S Ezziddin, K Reichmann, C Yong-Hing, et al.
Nuklearmedizin. Nuclear Medicine
|
April 30, 2014
Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement
A Sabet, F Khalaf, C J Yong-Hing, et al.
Page
of 2